This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Burkina Faso

  1. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization. The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This slide deck shares interim findings across the epidemiology, entomology, human behavior, and durability monitoring components of the five observational studies led by PATH.
    Published: August 2022
    Type: Resource Page
  2. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization (WHO). The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This report shares interim findings from the five observational studies led by PATH.
    Published: July 2022
    Type: Resource Page
  3. In many low- and middle-income countries, hundreds of thousands of people—including many newborns, children, and pregnant women—die needlessly each year from hypoxemia, or a low concentration of oxygen in the blood. Hypoxemia can be caused by a range of illnesses and complications, including pneumonia, neonatal infections, premature birth, obstetric emergencies, and respiratory infections like COVID-19.The COVID-19 pandemic has pointedly highlighted the lack of access to oxygen in lower-resource settings. The biggest barriers to oxygen therapy access include inadequate supply and human resource capacity, funding constraints, and the inability to deploy resources in countries rapidly in a way that ensures maximum impact while not overwhelming existing health care systems. The oxygen landscape is at a pivotal point where short-term pandemic-response efforts require continued support while transitioning to long-term, sustained strategies for ensuring access.This fact sheet offers an overview of the SOURCE project to support countries to equitably improve access to high-quality oxygen services at all levels of the health care system in order to reduce maternal, child, and overall mortality from hypoxemia-related causes. To do so, PATH will incorporate near-term pandemic-response work into a robust set of implementation, advocacy, and research activities that will ensure long-term access to medical oxygen and resilient systems for future pandemic-response efforts.
    Published: July 2022
    Type: Resource Page
  4. This report focuses on bed net indicators collected from annual cross-sectional surveys and anthropological activities. Within each evaluation, available indicators on bed net ownership, bed net characteristics, and bed net use are presented. Due to country-specific factors, the timing of data collection, management, and analysis varies. Data collection and analysis are ongoing, and definitive conclusions will not be drawn from these results at this time.The New Nets Project (NNP) was established with the goal of making the latest dual active ingredient (AI) insecticide-treated nets (ITNs) more widely available to malaria programs throughout sub-Saharan Africa. In addition to managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, NNP partners oversee randomized control trials and pilot studies evaluating their efficacy and effectiveness. The evidence gathered from these studies will be used to ascertain the impact and cost-effectiveness of dual AI nets and support an appropriate ITN policy recommendation from the World Health Organization. The NNP is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and US President’s Malaria Initiative. The project is led by IVCC.
    Published: May 2022
    Type: Resource Page
  5. The goal of the antenatal care (ANC)-based malaria surveillance study is to assess the potential for pregnant women attending their first ANC visit to be used as an easy-to-access sentinel population at health facilities to monitor trends in prevalence of malaria infection and the coverage of malaria control interventions in study districts, correlated with similar metrics obtained during annual community-based cross-sectional surveys (CSS). The New Nets Project (NNP) is conducting annual cross-sectional surveys in three study districts each in Burkina Faso and western Mozambique and in four study local government areas in Nigeria, with the primary aim of evaluating the impact of next-generation dual active ingredient insecticide-treated nets (ITNs) compared to standard pyrethroid-only ITNs. Through funding from the Bill & Melinda Gates Foundation and The Global Fund, testing for malaria of all pregnant women at during their first ANC visit is being implemented at select health facilities in NNP study districts for two years (2020–2022).This descriptive report presents a summary of preliminary results generated from the first months of data collection in Burkina Faso, Mozambique, and Nigeria. It begins with an overview of the study sites and timeline, followed by a summary of the study population and data collection and analysis methods. The findings from each country are then presented, including prevalence and ITN and care-seeking indicators. Each country section closes with a discussion on the ANC-based surveillance results and how they seemingly compare to results from the annual household CSSs from the NNP.
    Published: May 2022
    Type: Resource Page
  6. Mosquito nets treated with new ingredients show greater reductions in malaria than standard insecticide-treated nets.
    Published: December 2021
    Type: Article
  7. PATH and partners are helping countries make better investments in digital health by learning from those leading the way.
    Published: November 2021
    Type: Article
  8. In West Africa and around the world, scaling up access to oxygen is one of the most effective, and critical, actions that decision-makers can take to improve health outcomes, particularly for vulnerable populations such as newborns, children, and pregnant women. The COVID-19 pandemic has further emphasized the vital role of respiratory care for patients struggling to breathe. Respiratory care requires investment in strengthening health care delivery systems, including supply management and provider training.This brief summarizes Senegal’s and Burkina Faso’s efforts toward establishing a comprehensive and sustainable oxygen system to address respiratory care needs beyond COVID-19, and demonstrates the type of support PATH can provide in this process.
    Published: October 2021
    Type: Resource Page
  9. A great deal of knowledge already exists in the global health community regarding maternal, neonatal, and child health (MNCH) medical devices and the challenges/barriers they face. But this knowledge is currently scattered across a variety of donor, partner, country, and academic sources, and as a result, is not easily accessible to the broader community. As such, PATH—under the Market Dynamics for MNCH Medical Devices project (MD4MD)—conducted a rapid desk research exercise focused on compiling information that was either publicly available or easily accessible, including: published literature, multilateral organization resources (such as policy briefs, technical reports, and guidelines); implementing partner projects (such as assessments, landscapes, and technical reports); donor investment documents; and expert interviews with relevant project leads and medical device experts.This evidence review focuses on eight specific devices: (1) manual blood pressure cuff (sphygmomanometer); (2) electric bCPAP device; (3) neonatal resuscitation device; (4) x-ray radiography machine; (5) point-of-care hemoglobin meter; (6) infusion device; (7) ultrasound (app-based “pocket” devices); and (8) ultrasound (traditional portable devices).The goal of these documents is to (1) summarize for policymakers and health system leaders the most important barriers that MNCH devices face, and (2) highlight potential interventions and key knowledge gaps to prioritize with future investments.
    Published: July 2021
    Type: Resource Page
  10. Medical devices play an essential role in the prevention, diagnosis, and treatment of maternal, neonatal, and child health (MNCH) in low- and middle-income countries. However, medical devices have unique characteristics that make them difficult to manage effectively, particularly in low-resource settings.As countries experience rising life expectancy and a shift toward noncommunicable disease burden, demand is growing rapidly for device-intensive services like life support and chronic disease management. There is also an expectation that this growing need will be met with domestic rather than donor resources as countries move up in income status. Strengthening access to medical devices is therefore a critical area for health system investment.This fact sheet offers an overview of the Market Dynamics for MNCH Medical Devices project (MD4MD), which aims to diagnose key barriers that impede access to MNCH medical devices in low- and middle-income countries and prioritize potential solutions to address these barriers.
    Published: March 2021
    Type: Resource Page
Load more